METTL9 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.800000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.173400E-01
Normal-vs-Stage2
9.335800E-01
Normal-vs-Stage3
4.477200E-01
Normal-vs-Stage4
4.868600E-01
Stage1-vs-Stage2
4.948800E-01
Stage1-vs-Stage3
5.501000E-01
Stage1-vs-Stage4
2.114000E-01
Stage2-vs-Stage3
2.142200E-01
Stage2-vs-Stage4
2.874600E-01
Stage3-vs-Stage4
2.143000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.896800E-01
Normal-vs-AfricanAmerican
7.273800E-01
Normal-vs-Asian
7.783800E-01
Caucasian-vs-AfricanAmerican
7.310000E-01
Caucasian-vs-Asian
5.961400E-01
AfricanAmerican-vs-Asian
4.664000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.961800E-01
Normal-vs-Female
9.474600E-01
Male-vs-Female
7.991200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.845200E-01
Normal-vs-Age(41-60Yrs)
6.009800E-01
Normal-vs-Age(61-80Yrs)
8.772200E-01
Normal-vs-Age(81-100Yrs)
6.184800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.183400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.105800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.617600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.302300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.966500E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.298600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.436200E-01
Normal-vs-Daily Drinker
8.896200E-01
Normal-vs-Weekly Drinker
7.825200E-01
Normal-vs-Occasional Drinker
5.977400E-01
Normal-vs-Social Drinker
8.408600E-01
Non Drinker-vs-Daily Drinker
7.741800E-01
Non Drinker-vs-Weekly Drinker
8.890400E-01
Non Drinker-vs-Occasional Drinker
7.771900E-02
Non Drinker-vs-Social Drinker
7.238200E-01
Daily Drinker-vs-Weekly Drinker
9.038000E-01
Daily Drinker-vs-Occasional Drinker
2.107600E-01
Daily Drinker-vs-Social Drinker
9.686200E-01
Weekly Drinker-vs-Occasional Drinker
1.727580E-01
Weekly Drinker-vs-Social Drinker
8.435200E-01
Occasional Drinker-vs-Social Drinker
1.712360E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.173030E-01
Normal-vs-Grade 2
1.295900E-02
Normal-vs-Grade 3
2.719900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.061900E-03
Grade 1-vs-Grade 3
3.406200E-02
Grade 1-vs-Grade 4
1.173030E-01
Grade 2-vs-Grade 3
5.761000E-01
Grade 2-vs-Grade 4
1.295900E-02
Grade 3-vs-Grade 4
2.719900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.261400E-01
Normal-vs-NonDiabetic
9.687600E-01
Diabetic-vs-NonDiabetic
8.160600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.791800E-01
Normal-vs-NoPancreatitis
9.823600E-01
Pancreatitis-vs-NoPancreatitis
1.587180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.555400E-01
Normal-vs-N1
9.565800E-01
N0-vs-N1
9.976800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.149000E-01
Normal-vs-TP53-NonMutant
9.595000E-01
TP53-Mutant-vs-TP53-NonMutant
2.161800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
